Edwards Lifesciences
1,225 hedge funds and large institutions have $38.1B invested in Edwards Lifesciences in 2025 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 430 increasing their positions, 437 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 1,247 → 1,225 (-22)
2.05% less ownership
Funds ownership: 85.53% → 83.48% (-2%)
13% less call options, than puts
Call options by funds: $295M | Put options by funds: $337M
Holders
1,225
Holding in Top 10
10
Calls
$295M
Puts
$337M
Top Buyers
| 1 | +$937M | |
| 2 | +$320M | |
| 3 | +$239M | |
| 4 |
Jennison Associates
New York
|
+$178M |
| 5 |
Bank of New York Mellon
New York
|
+$111M |
Top Sellers
| 1 | -$661M | |
| 2 | -$381M | |
| 3 | -$259M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$179M |
| 5 |
JP Morgan Chase
New York
|
-$133M |